Nutex Health Inc.
NUTXNasdaqCIK 1479681IndustrialsFiscal year ends Dec 31
Reports and events: 226 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-05-0918:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-007416 |
| 2024-05-0918:26 ET | 10-Q | Quarterly reportPeriod 2024-03-31 | 0001558370-24-007414 |
| 2024-05-0616:46 ET | DEF 14A | Proxy statementPeriod 2024-06-17 | 0001104659-24-057492 |
| 2024-04-3013:59 ET | 10-K/A | Annual report, amendedPeriod 2023-12-31 | 0001558370-24-006236 |
| 2024-04-1110:31 ET | 8-K | 3.03 Change to security holders’ rights; 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001558370-24-004950 |
| 2024-04-0817:08 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-004842 |
| 2024-03-2917:33 ET | 10-K | Annual reportPeriod 2023-12-31 | 0001558370-24-004287 |
| 2024-03-2817:27 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-24-004285 |
| 2024-02-2916:37 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-002198 |
| 2024-02-1516:53 ET | 8-K | 1.02 Termination of a material agreement; 9.01 Financial statements and exhibits | 0001558370-24-001249 |
| 2024-02-0916:59 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001558370-24-000941 |
| 2024-01-2416:45 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0001104659-24-006283 |
| 2024-01-1110:59 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-24-000199 |
| 2023-11-2715:49 ET | 8-K | 3.01 Delisting notice | 0001558370-23-019325 |
| 2023-11-0916:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-018565 |
| 2023-11-0916:04 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0001558370-23-018558 |
| 2023-09-0517:27 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-015462 |
| 2023-08-2312:57 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-015209 |
| 2023-08-0915:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-014214 |
| 2023-08-0915:03 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0001558370-23-014212 |
| 2023-07-0517:12 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001558370-23-011705 |
| 2023-05-2616:31 ET | 8-K | 3.01 Delisting notice | 0001558370-23-010549 |
| 2023-05-1914:17 ET | DEF 14A | Proxy statement | 0001104659-23-062628 |
| 2023-05-1516:34 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001558370-23-009897 |
| 2023-05-1516:32 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0001558370-23-009892 |
| 2023-05-0220:58 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001558370-23-007550 |
| 2023-04-1209:07 ET | 8-K | 1.01 Entry into a material agreement; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-044380 |
| 2023-04-0615:04 ET | 10-K/A | Annual report, amendedPeriod 2022-12-31 | 0001104659-23-042612 |
| 2023-04-0517:19 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001104659-23-042250 |
| 2023-03-0317:48 ET | 10-K | Annual reportPeriod 2022-12-31 | 0001558370-23-002713 |
| 2023-03-0217:29 ET | 8-K | 2.02 Results of operations; 8.01 Other events; 9.01 Financial statements and exhibits | 0001558370-23-002711 |
| 2023-02-2817:44 ET | 8-K | 7.01 Regulation FD disclosure | 0001607062-23-000112 |
| 2023-01-0416:02 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-23-000002 |
| 2022-12-2116:45 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-22-000759 |
| 2022-11-2218:40 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001607062-22-000733 |
| 2022-11-2117:19 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0001607062-22-000727 |
| 2022-11-1816:59 ET | 8-K | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001607062-22-000716 |
| 2022-10-1114:33 ET | 8-K | 8.01 Other events | 0001607062-22-000619 |
| 2022-08-2216:32 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001607062-22-000550 |
| 2022-08-2216:32 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001607062-22-000548 |
| 2022-06-1606:51 ET | 8-K/A | 2.01 Completion of an acquisition or disposition; 8.01 Other events; 9.01 Financial statements and exhibits | 0001607062-22-000426 |
| 2022-06-1014:49 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-22-000411 |
| 2022-05-1317:23 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001607062-22-000334 |
| 2022-04-2615:47 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001607062-22-000306 |
| 2022-04-1113:53 ET | SC 13D | Ownership report, active investor | 0001607062-22-000268 |
| 2022-04-1113:51 ET | SC 13D | Ownership report, active investor | 0001607062-22-000266 |
| 2022-04-0417:05 ET | 8-K | 2.01 Completion of an acquisition or disposition; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.01 Change in control; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-22-000244 |
| 2022-03-3116:22 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001607062-22-000229 |
| 2022-03-1719:08 ET | 8-K | 5.07 Shareholder vote results; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001607062-22-000193 |
| 2021-12-1513:42 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001607062-21-000618 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 16:37 ET. Listed shows no prices and gives no investment advice.